Ocriplasmin ophthalmic Side Effects
Medically reviewed by Drugs.com. Last updated on Aug 20, 2020.
More frequently reported side effects include: decreased visual acuity and intraocular inflammation. See below for a comprehensive list of adverse effects.
For the Consumer
Applies to ocriplasmin ophthalmic: intraocular solution
Side effects requiring immediate medical attention
Along with its needed effects, ocriplasmin ophthalmic may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor or nurse immediately if any of the following side effects occur while taking ocriplasmin ophthalmic:
- Bloody eyes
- blurred vision or other change in vision
- decreased vision
- eye pain
- redness of the eye
- seeing flashes or sparks of light
- sensitivity of the eye to light
- Change in color vision
- difficulty seeing at night
- eye discomfort
- loss of vision
- seeing floating spots before the eyes, or a veil or curtain appearing across part of vision
- throbbing pain
Side effects not requiring immediate medical attention
Some side effects of ocriplasmin ophthalmic may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
- Dry eyes
For Healthcare Professionals
Applies to ocriplasmin ophthalmic: intravitreal solution
The most commonly reported side effects included vitreous floaters, eye pain, photopsia, and blurred vision.[Ref]
Very common (10% or more): Vitreous floaters (up to 16.8%), macular hole (up to 15.8%), eye pain (up to 13.1%), photopsia (up to 11.8%), chromatopsia, conjunctival hemorrhage
Common (1% to 10%): Abnormal optical coherence tomography (OCT), anterior chamber cell, anterior chamber flare, blurred vision, conjunctival edema, conjunctival hyperemia, cystoid macular edema, decreased best corrected visual acuity (BCVA), dry eye, dyschromatopsia, eye irritation, eye pruritus, eyelid edema, foreign body sensation in eyes, increased intraocular pressure, increased lacrimation, iritis, macular degeneration, macular edema, metamorphopsia, ocular discomfort, ocular hyperemia, photophobia, photopsia, reduced visual acuity, retinal breaks, retinal degeneration, retinal edema, retinal hemorrhage, retinal pigment epitheliopathy, subretinal fluid, visual impairment, vitreous detachment, vitreous hemorrhage, vitritis
Uncommon (0.1% to 1%): Anterior chamber inflammation, conjunctival irritation, corneal abrasion, diplopia, eye inflammation, hyphema, lens subluxation, miosis, night blindness, retinal detachment, retinal tear, serious acute visual impairment, severe acute visual impairment, transient blindness, unequal pupils
Frequency not reported: Dim vision, macular hole progression
Postmarketing reports: Impaired pupillary reflex[Ref]
Very common (10% or more): Abnormal color vision test, abnormal retinogram
Common (1% to 10%): Abnormal macular reflex, increased intraocular pressure, visual field defect, visual symptoms perceived in the contralateral eye
Frequency not reported: Scotoma[Ref]
Common (1% to 10%): Intravitreal injection procedure associated effects[Ref]
Frequency not reported: Immunogenicity[Ref]
1. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
2. Cerner Multum, Inc. "Australian Product Information." O 0
3. "Product Information. Jetrea (ocriplasmin ophthalmic)." ThromboGenics Inc, Iselin, NJ.
More about ocriplasmin ophthalmic
- Other brands
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.